Hopper Jonathan Mark, Chief Medical Officer of Vericel Corp ($VCEL), made three open market sales of company shares over the last year, totaling $823 thousand. His most recent sale occurred on December 2, 2025. These transactions rank 5,358th out of 11,678 individual insiders in our database, below the average sale amount of $8.6 million across 6 transactions per insider. He reported no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 24, 2026 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | F | Common Stock | 1335 | $38.09 | 73,192.0000 | 51,908,000 | 1.79% | 0.00% |
| Feb. 24, 2026 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | M | Common Stock | 3150 | $0.00 | 74,527.0000 | 51,908,000 | 4.41% | 0.01% |
| Feb. 24, 2026 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | M | Common Stock | 350 | $0.00 | 71,377.0000 | 51,908,000 | 0.49% | 0.00% |
| Feb. 24, 2026 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | M | Restricted Stock Unit | 1500 | $0.00 | 6,000.0000 | 51,908,000 | 33.33% | 0.00% |
| Feb. 24, 2026 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | M | Restricted Stock Unit | 1500 | $0.00 | 7,500.0000 | 51,908,000 | 25.00% | 0.00% |
| Feb. 24, 2026 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | M | Restricted Stock Unit | 3150 | $0.00 | 10,500.0000 | 51,908,000 | 42.86% | 0.01% |
| Feb. 24, 2026 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | M | Restricted Stock Unit | 350 | $0.00 | 13,650.0000 | 51,908,000 | 2.63% | 0.00% |
| Feb. 24, 2026 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | F | Common Stock | 636 | $38.25 | 75,556.0000 | 51,908,000 | 0.83% | 0.00% |
| Feb. 24, 2026 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | M | Common Stock | 1500 | $0.00 | 76,192.0000 | 51,908,000 | 2.01% | 0.00% |
| Feb. 24, 2026 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | M | Common Stock | 1500 | $0.00 | 74,692.0000 | 51,908,000 | 2.05% | 0.00% |
| Feb. 19, 2026 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | A | Restricted Stock Unit | 14000 | $0.00 | 14,000.0000 | 51,908,000 | 9999.99% | 0.03% |
| Feb. 18, 2026 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | M | Common Stock | 3000 | $0.00 | 69,684.0000 | 51,908,000 | 4.50% | 0.01% |
| Feb. 18, 2026 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | M | Common Stock | 2325 | $0.00 | 72,009.0000 | 51,908,000 | 3.34% | 0.00% |
| Feb. 18, 2026 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | F | Common Stock | 982 | $37.41 | 71,027.0000 | 51,908,000 | 1.36% | 0.00% |
| Feb. 18, 2026 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | M | Restricted Stock Unit | 3000 | $0.00 | 3,000.0000 | 51,908,000 | 9999.99% | 0.01% |
| Feb. 18, 2026 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | M | Restricted Stock Unit | 2325 | $0.00 | 0.0000 | 51,908,000 | 0.00% | 0.00% |
| Feb. 19, 2026 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | A | Stock Option (Right to Buy) | 35000 | $0.00 | 35,000.0000 | 51,908,000 | 9999.99% | 0.07% |
| Dec. 31, 2025 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | A | Common Stock | 122 | $26.27 | 66,684.0000 | 51,908,000 | 0.18% | 0.00% |
| Dec. 2, 2025 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | M | Stock Option (Right to Buy) | 1652 | $0.00 | 7,098.0000 | 51,908,000 | 30.33% | 0.00% |
| Dec. 2, 2025 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | M | Common Stock | 1652 | $18.00 | 68,214.0000 | 51,908,000 | 2.48% | 0.00% |
| Dec. 2, 2025 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | S | Common Stock | 1652 | $39.14 | 66,562.0000 | 51,908,000 | 2.42% | 0.00% |
| Sept. 2, 2025 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | S | Common Stock | 10000 | $35.77 | 66,363.0000 | 51,679,000 | 13.10% | 0.02% |
| Sept. 2, 2025 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | M | Stock Option (Right to Buy) | 10000 | $0.00 | 8,750.0000 | 51,679,000 | 0.00% | 0.02% |
| Sept. 2, 2025 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | M | Common Stock | 10000 | $18.00 | 76,363.0000 | 51,679,000 | 15.07% | 0.02% |
| June 2, 2025 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | M | Stock Option (Right to Buy) | 10000 | $0.00 | 18,750.0000 | 51,679,000 | 114.29% | 0.02% |
| June 2, 2025 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | S | Common Stock | 10000 | $40.09 | 66,237.0000 | 51,679,000 | 13.12% | 0.02% |
| June 2, 2025 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | M | Common Stock | 10000 | $18.00 | 76,237.0000 | 51,679,000 | 15.10% | 0.02% |
| March 3, 2025 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | S | Common Stock | 10000 | $49.53 | 66,101.0000 | 51,679,000 | 13.14% | 0.02% |
| March 3, 2025 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | M | Stock Option (Right to Buy) | 10000 | $0.00 | 28,750.0000 | 51,679,000 | 53.33% | 0.02% |
| March 3, 2025 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | M | Common Stock | 10000 | $18.00 | 76,101.0000 | 51,679,000 | 15.13% | 0.02% |
| Feb. 24, 2025 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | F | Common Stock | 636 | $52.33 | 66,101.0000 | 51,679,000 | 0.95% | 0.00% |
| Feb. 24, 2025 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | M | Common Stock | 1500 | $0.00 | 65,237.0000 | 51,679,000 | 2.35% | 0.00% |
| Feb. 24, 2025 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | M | Common Stock | 1500 | $0.00 | 66,737.0000 | 51,679,000 | 2.30% | 0.00% |
| Feb. 24, 2025 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | M | Restricted Stock Unit | 1500 | $0.00 | 10,500.0000 | 51,679,000 | 16.67% | 0.00% |
| Feb. 24, 2025 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | M | Restricted Stock Unit | 1500 | $0.00 | 9,000.0000 | 51,679,000 | 20.00% | 0.00% |
| Feb. 20, 2025 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | A | Restricted Stock Unit | 14000 | $0.00 | 14,000.0000 | 51,679,000 | 9999.99% | 0.03% |
| Feb. 20, 2025 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | A | Stock Option (Right to Buy) | 35000 | $0.00 | 35,000.0000 | 51,679,000 | 9999.99% | 0.07% |
| Feb. 18, 2025 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | M | Common Stock | 2325 | $0.00 | 63,825.0000 | 51,679,000 | 3.78% | 0.00% |
| Feb. 18, 2025 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | F | Common Stock | 985 | $57.28 | 62,840.0000 | 51,679,000 | 1.54% | 0.00% |
| Feb. 19, 2025 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | M | Common Stock | 1750 | $0.00 | 64,590.0000 | 51,679,000 | 2.78% | 0.00% |
| Feb. 19, 2025 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | F | Common Stock | 853 | $57.78 | 63,737.0000 | 51,679,000 | 1.32% | 0.00% |
| Feb. 18, 2025 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | M | Restricted Stock Unit | 3000 | $0.00 | 6,000.0000 | 51,679,000 | 100.00% | 0.01% |
| Feb. 18, 2025 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | M | Restricted Stock Unit | 2325 | $0.00 | 2,325.0000 | 51,679,000 | 9999.99% | 0.00% |
| Feb. 19, 2025 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | M | Restricted Stock Unit | 1750 | $0.00 | 0.0000 | 51,679,000 | 0.00% | 0.00% |
| Feb. 18, 2025 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | M | Common Stock | 3000 | $0.00 | 61,500.0000 | 51,679,000 | 5.13% | 0.01% |
| Dec. 31, 2024 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | A | Common Stock | 129 | $34.04 | 58,500.0000 | 49,085,000 | 0.22% | 0.00% |
| Dec. 2, 2024 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | S | Common Stock | 10000 | $58.72 | 58,371.0000 | 49,085,000 | 14.63% | 0.02% |
| Dec. 2, 2024 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | M | Common Stock | 10000 | $16.66 | 68,371.0000 | 49,085,000 | 17.13% | 0.02% |
| Dec. 2, 2024 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | M | Stock Option (Right to Buy) | 10000 | $0.00 | 6,000.0000 | 49,085,000 | 0.00% | 0.02% |
| Sept. 3, 2024 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | M | Stock Option (Right to Buy) | 10000 | $0.00 | 12,604.0000 | 47,590,000 | 384.02% | 0.02% |
| Sept. 3, 2024 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | S | Common Stock | 10000 | $49.83 | 58,229.0000 | 47,590,000 | 14.66% | 0.02% |
| Sept. 3, 2024 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | M | Common Stock | 10000 | $10.95 | 68,229.0000 | 47,590,000 | 17.17% | 0.02% |
| May 20, 2024 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | M | Stock Option (Right to Buy) | 10000 | $0.00 | 22,604.0000 | 47,590,000 | 79.34% | 0.02% |
| May 20, 2024 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | M | Common Stock | 10000 | $10.95 | 68,116.0000 | 47,590,000 | 17.21% | 0.02% |
| May 20, 2024 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | S | Common Stock | 10000 | $49.99 | 58,116.0000 | 47,590,000 | 14.68% | 0.02% |
| Feb. 22, 2024 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | A | Restricted Stock Unit | 12000 | $0.00 | 12,000.0000 | 47,590,000 | 9999.99% | 0.03% |
| Feb. 22, 2024 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | A | Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 47,590,000 | 9999.99% | 0.06% |
| Feb. 20, 2024 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | M | Common Stock | 2325 | $0.00 | 57,930.0000 | 47,590,000 | 4.18% | 0.00% |
| Feb. 20, 2024 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | M | Common Stock | 1750 | $0.00 | 58,695.0000 | 47,590,000 | 3.07% | 0.00% |
| Feb. 20, 2024 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | F | Common Stock | 985 | $49.50 | 56,945.0000 | 47,590,000 | 1.70% | 0.00% |
| Feb. 20, 2024 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | M | Common Stock | 3000 | $0.00 | 56,984.0000 | 47,590,000 | 5.56% | 0.01% |
| Feb. 20, 2024 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | F | Common Stock | 1379 | $49.50 | 55,605.0000 | 47,590,000 | 2.42% | 0.00% |
| Feb. 20, 2024 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | M | Restricted Stock Unit | 2325 | $0.00 | 4,650.0000 | 47,590,000 | 100.00% | 0.00% |
| Feb. 20, 2024 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | M | Restricted Stock Unit | 3000 | $0.00 | 9,000.0000 | 47,590,000 | 50.00% | 0.01% |
| Feb. 20, 2024 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | F | Common Stock | 742 | $49.50 | 57,953.0000 | 47,590,000 | 1.26% | 0.00% |
| Feb. 20, 2024 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | M | Restricted Stock Unit | 1750 | $0.00 | 1,750.0000 | 47,590,000 | 9999.99% | 0.00% |
| Feb. 12, 2024 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | M | Common Stock | 1625 | $0.00 | 54,759.0000 | 47,590,000 | 3.06% | 0.00% |
| Feb. 12, 2024 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | F | Common Stock | 775 | $47.42 | 53,984.0000 | 47,590,000 | 1.42% | 0.00% |
| Feb. 12, 2024 | Vericel Corp | $VCEL | Hopper Jonathan Mark | Chief Medical Officer | M | Restricted Stock Unit | 1625 | $0.00 | 0.0000 | 47,590,000 | 0.00% | 0.00% |